Financial Reports Latest Updates Industry Maps Economic Calendar

SBC Medical Group Holdings Inc (SBC) Annual Reports

Q: Where can I read SBC Medical Group Holdings Inc (SBC) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

SBC Medical Group Holdings Inc is listed on Nasdaq, classified by the SEC under Services-Offices & Clinics of Doctors of Medicine (SIC 8011). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1930313 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$49.2M	$43.4M	+13.4%
Operating income	$19.0M	$14.6M	+30.3%
Net income	$10.7M	$2.5M	+335.0%
EPS (diluted)	$0.10	$0.02	+400.0%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 49.2 mn Net income 10.7 mn

Show table：Income statement

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	—	—	47.3	62.4	54.8	53.1	53.1	44.4	47.3	43.4	43.4	39.6	43.1	49.2
Gross profit	—	—	—	—	—	—	33.5	43.4	39.5	39.4	43.2	33.9	37.7	30.0	30.6	28.9	30.4	36.0
Operating income	0	0	-0.3	-0.24	-0.39	-0.47	-0.32	-0.59	-0.5	-0.5	13.8	4.72	24.2	14.6	15.9	12.8	17.7	19.0
Net income	0	0	-0.01	0.57	0.61	0.2	-0.1	-0.37	-0.29	-0.31	2.83	6.54	21.5	2.46	12.8	14.2	11.3	10.7

Balance sheet

Quarterly · In mn (USD)

Total assets 407 mn Total liabilities 127 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	0.18	0.84	0.72	0.47	1.15	0.74	0.39	1.77	1.44	202	184	215	241	227	231	239	259
Total assets	—	0.36	119	120	121	21.6	21.4	21.3	19.8	19.5	296	266	285	315	321	380	388	407
Current liabilities	—	—	0.26	0.57	0.84	2.49	2.45	2.61	4.40	4.48	72.4	61.2	48.5	60.7	44.6	61.1	62.6	78.5
Total liabilities	—	0.34	4.29	4.59	4.86	6.51	6.47	6.63	8.43	8.51	91.0	71.1	58.3	70.7	73.3	117	118	127
Equity	0.02	0.02	-3.16	-3.36	-3.73	-5.21	-5.57	-5.99	9.02	8.83	205	195	226	245	248	248	255	264

Cash flow

Quarterly · In mn (USD)

Operating 22.5 mn Investing 0.57 mn Financing -1.96 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	—	-0.01	-0.36	-0.09	-0.39	-0.92	-0.4	-0.42	-0.49	-0.41	28.8	-7.30	1.93	-8.34	-20.9	52.0	9.23	22.5
Investing	—	—	-118	0	0.13	101	0	0.13	3.13	0.13	-8.81	-4.55	-0.98	16.4	-12.2	-24.2	-0.53	0.57
Financing	—	0.19	119	0	—	-99.1	0	0	-1.26	0	12.8	11.4	-0.28	7.18	11.6	19.8	-1.84	-1.96
Cash at period end	—	0.18	0.58	0.49	—	0.97	—	103	—	1.38	137	125	132	153	127	164	167	184

Profitability

Quarterly · %

Gross margin 73.1% Operating margin 38.5% Net margin 21.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	—	—	70.8%	69.6%	72.1%	74.2%	81.5%	76.3%	79.7%	69.2%	70.6%	73.1%	70.5%	73.1%
Operating margin	—	—	—	—	—	—	-0.7%	-0.9%	-0.9%	-0.9%	26.1%	10.6%	51.1%	33.6%	36.6%	32.5%	41.1%	38.5%
Net margin	—	—	—	—	—	—	-0.2%	-0.6%	-0.5%	-0.6%	5.3%	14.7%	45.4%	5.7%	29.6%	35.9%	26.3%	21.7%

Returns & leverage

Quarterly · %

ROE 19.3% ROA 13.6% Debt ratio 31.2%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	-21.4%	-59.1%	1.9%	9.3%	26.0%	26.3%	19.1%	23.0%	16.9%	19.3%
ROA	—	—	—	0.5%	1.0%	12.4%	1.8%	0.5%	-0.8%	-5.2%	1.2%	6.1%	20.1%	19.9%	14.0%	15.8%	12.1%	13.6%
Debt ratio	—	93.5%	3.6%	3.8%	4.0%	30.1%	30.2%	31.2%	42.7%	43.6%	30.7%	26.7%	20.5%	22.4%	22.8%	30.8%	30.3%	31.2%

EPS

Quarterly · US$

EPS US$0.10

Show table：EPS

Item	2023Q1	2023Q1	2023Q1	2023Q1	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	0.09	0.15	0.20	0.20	0.03	0.06	0.21	0.02	0.12	0.14	0.11	0.10

Revenue & profit

Year-to-date · In mn (USD)

Revenue 92.3 mn Net income 22.0 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 407 mn Total liabilities 127 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 31.7 mn Investing 0.04 mn Financing -3.80 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 71.9% Operating margin 39.8% Net margin 23.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 19.3% ROA 13.6% Debt ratio 31.2%

EPS

Year-to-date · US$

EPS US$0.21

Revenue & profit

Annual · In mn (USD)

Revenue 174 mn Net income 51.0 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2023	2024	2025
Revenue	—	205	174
Gross profit	—	156	127
Operating income	-2.32	17.6	67.5
Net income	0.89	8.77	51.0

Balance sheet

Annual · In mn (USD)

Total assets 380 mn Total liabilities 117 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2023	2024	2025
Current assets	0.39	184	231
Total assets	21.3	266	380
Current liabilities	2.61	61.2	61.1
Total liabilities	6.63	71.1	117
Equity	-5.99	195	248

Cash flow

Annual · In mn (USD)

Operating 24.7 mn Investing -21.0 mn Financing 38.3 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2023	2024	2025
Operating	—	20.6	24.7
Investing	—	-10.1	-21.0
Financing	—	23.0	38.3
Cash at period end	103	125	164

Profitability

Annual · %

Gross margin 73.3% Operating margin 38.9% Net margin 29.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2023	2024	2025
Gross margin	—	76.0%	73.3%
Operating margin	—	8.5%	38.9%
Net margin	—	4.3%	29.4%

Returns & leverage

Annual · %

ROE 23.0% ROA 15.8% Debt ratio 30.8%

Show table：Returns & leverage

Item	2023	2024	2025
ROE	—	9.3%	23.0%
ROA	4.2%	6.1%	15.8%
Debt ratio	31.2%	26.7%	30.8%

EPS

Annual · US$

EPS US$0.49

Show table：EPS

Item	2023	2024	2025
EPS（US$）	—	0.49	0.49

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read SBC Medical Group Holdings Inc (SBC) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.